Humle Småbolagsfond vs UBS Lux Equity Fund Biotech USD

Humle Småbolagsfond vs UBS Lux Equity Fund Biotech USD

1. Humle Småbolagsfond

  • Security

    Humle Småbolagsfond A

  • Fee

    1.50%

  • ISIN

    SE0002229658

  • Holdings

    17

  • Number of owning funds

    2

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 22 holdings in Humle Småbolagsfond, where the largest holding is Sectra (4.27), followed by Avanza (4.05) and Beijer Ref B (3.91). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Humle Småbolagsfond and UBS Lux Equity Fund Biotech USD.

Humle Småbolagsfond UBS Lux Equity Fund Biotech USD
1. Sectra B
Sweden
4.27 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Avanza Bank Holding
Sweden
4.05 %
2. Moderna Inc
9.21 %
3. Beijer Ref B
Sweden
3.91 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Addtech B
Sweden
3.73 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Securitas B
Sweden
3.63 %
5. AbbVie Inc
USA
4.91 %
6. Sagax B
Sweden
3.5 %
6. Gilead Sciences Inc
USA
4.66 %
7. AAK Sweden AB
Sweden
3.38 %
7. Amgen Inc
USA
4.43 %
8. Nordnet Bank AB
Sweden
3.31 %
8. BioNTech SE
4.13 %
9. Trelleborg B
Sweden
3.28 %
9. Karuna Therapeutics Inc
3.75 %
10. Lagercrantz Group B
Sweden
2.84 %
-
11. Nyfosa AB
Sweden
2.73 %
-
12. Karnov Group Sweden AB
Sweden
2.64 %
-
13. Bravida Holding
2.58 %
-
14. Vitec Software Group B
Sweden
2.51 %
-
15. Loomis B
Sweden
2.47 %
-
16. Gränges
2.41 %
-
17. Fortnox AB
Sweden
2.2 %
-

The list of fund holdings was last updated on July 27, 2025.